Clinical Trial to Demonstrate the Safety and Efficacy of DUOFAG®
Phase 1
Recruiting
- Conditions
- Surgical Wound InfectionSurgical Site InfectionPseudomonas Aeruginosa InfectionBacterial InfectionsStaphylococcus Aureus Infection
- Interventions
- Drug: PlaceboDrug: IMP
- First Posted Date
- 2024-03-19
- Last Posted Date
- 2024-03-19
- Lead Sponsor
- MB PHARMA s.r.o.
- Target Recruit Count
- 52
- Registration Number
- NCT06319235
- Locations
- 🇨🇿
St. Anne's University Hospital Brno, Brno, Czech Republic, Czechia
© Copyright 2025. All Rights Reserved by MedPath